Company profile
Vivere Oncotherapies
Vivere Oncotherapies is developing novel products with improved delivery & efficacy using our proprietary platform.
- Industry
- Biotechnology Research
- Employees
- 14
- Headquarters
- Berkeley, California
- Founded
- 2022
- LinkedIn followers
- 1,017
- Office locations
- 1
Vivere Oncotherapies company summary
Vivere Oncotherapies is a company in the Biotechnology Research industry, headquartered in Berkeley, California, founded in 2022. On LinkedIn the company has around 14 employees and 1,017 followers.
What technology does Vivere Oncotherapies use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Vivere Oncotherapies
Vivere Oncotherapies’ mission is to revolutionize gene therapy delivery to unlock the full potential of immunotherapy for cold, solid tumors. Vivere Oncotherapies is developing best-in-class, IV-administered oncotherapy products with improved delivery, efficacy, and safety for the treatment of solid cancers using our proprietary discovery platform. Our experienced leadership team is applying our powerful protein engineering platform to generate improved delivery vehicles that can selectively replicate within tumors, mediate multi-tumor antigen targeting by immune cells, and express multiple cargoes that overcome the immunosuppressive environment of cold tumors. We are on a bold mission to provide solutions to patients with immunologically cold, solid tumors for which there are not effective standards of care.
Where is Vivere Oncotherapies located?
Vivere Oncotherapies lists 1 location.
Compare companies similar to Vivere Oncotherapies
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Vivere Oncotherapies viveretx.com | Biotechnology Research | 14 | 2022 | Berkeley, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Vivere Oncotherapies
What does Vivere Oncotherapies do?
Vivere Oncotherapies’ mission is to revolutionize gene therapy delivery to unlock the full potential of immunotherapy for cold, solid tumors. Vivere Oncotherapies is developing best-in-class, IV-administered oncotherapy products with improved delivery, efficacy, and safety for the treatment of solid cancers using our proprietary discovery platform. Our experienced leadership team is applying our powerful protein engineering platform to generate improved delivery vehicles that can selectively replicate within tumors, mediate multi-tumor antigen targeting by immune cells, and express multiple cargoes that overcome the immunosuppressive environment of cold tumors. We are on a bold mission to provide solutions to patients with immunologically cold, solid tumors for which there are not effective standards of care.
How many employees does Vivere Oncotherapies have?
Vivere Oncotherapies has around 14 employees on LinkedIn.
Where is Vivere Oncotherapies headquartered?
Vivere Oncotherapies is headquartered in Berkeley, California.
When was Vivere Oncotherapies founded?
Vivere Oncotherapies was founded in 2022.
Build a lead list from companies like Vivere Oncotherapies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.